secwatch.observer — SEC 8-K summary
======================================

Issuer:     XBiotech Inc. (XBIT)
CIK:        0001626878
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001171843-25-002067
Event type: regulatory
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Director W. Thorpe McKenzie retires; XBiotech to maintain one-member audit and compensation committees
--------------------------------------------------------------------------------

- W. Thorpe McKenzie retired from the Board effective March 27, 2025.
- Company notified NASDAQ on April 1, 2025, of the retirement and intent to fill vacancies.
- Audit Committee and Compensation Committee will each operate with one member under NASDAQ exceptions.
- Vacancies to be filled within the time prescribed by NASDAQ Rules 5605(c)(4) and 5605(d)(4).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626878/000117184325002067/0001171843-25-002067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626878/000117184325002067/f8k_040725.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-002067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer